QUICK-CLOSE VASCULAR SUTURING SYSTEM (QUICK-CLOSE SYSTEM)

FDA Premarket Approval P080029

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the quick-close vascular suturing system. This device is indicated as follows:the quick-close vascular suturing system is indicated to close femoral artery accesssites and to reduce time-to-hemostasis and time-to-ambulation in patients who haveundergone diagnostic or interventional endovascular procedures utilizing a 5, 6, 7, or 8french procedural sheath. Additionally, the quick-close vascular suturing system is indicated to reduce time-to-hemostasis in patients who have undergone interventionalendovascular procedures utilizing a 5, 6, 7, or 8 french procedural sheath, who havereceived intraprocedural glycoprotein iib/iiia inhibitor therapy.

DeviceQUICK-CLOSE VASCULAR SUTURING SYSTEM (QUICK-CLOSE SYSTEM)
Generic NameDevice, Hemostasis, Vascular
ApplicantCardiva Medical, Inc.
Date Received2008-12-05
Decision Date2010-04-08
Notice Date2010-04-23
PMAP080029
SupplementS
Product CodeMGB 
Docket Number10M-0220
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Cardiva Medical, Inc. 2900 Lakeside Drive suite 160 santa Clara, CA 95054
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P080029Original Filing
S002 2014-11-26 30-day Notice
S001 2010-08-18 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.